Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

A challenge we can no longer ignore: meeting the needs of people with Crohn’s Disease in the UK

August 3, 2025 Research and Development Crohn’s disease, Immunology, Lilly UK, autoimmune disease, immunology

By Holly Thomas, Associate Vice-President Specialty Care at Lilly UK and Ireland Immunology care in the UK is at a …
Feature

Ryvu Therapeutics publishes research revealing potential drug combination for colorectal cancer

August 1, 2025 Medical Communications, Research and Development Oncology, Ryvu Therapeutics, colorectal cancer

Ryvu Therapeutics has published new findings from its ONCO Prime target discovery platform in Scientific Reports. The study reveals a …
News

Richmond Pharmacology appoints Priscilla Ochuba as associate medical director

August 1, 2025 Research and Development Contract Research Organsation, Corporate, Pharmacy, Richmond Pharmacology, associate medical director

Richmond Pharmacology has announced the promotion of Priscilla Ochuba to associate medical director, effective 1 August 2025. The move recognises …
Appointment

Labguru and Titian Software rebrand as Cenevo to accelerate connected labs

July 31, 2025 Analytical & Laboratory Services, Research and Development Cenevo, Corporate, Labguru, Laboratory management

Lab management companies, Labguru and Titian Software, have rebranded under a new unified name, Cenevo. This combines their solutions, Mosaic …
News
lab

Hansa Biopharma bolsters leadership team with new executive appointments

July 31, 2025 Research and Development Chief Human Resources Officer, Chief Legal Officer, Corporate, Executive Leadership Team, Hansa Biopharma, Vice President Corporate Affairs

Hansa Biopharma has announced three senior leadership appointments to support its global expansion as well as pre-commercial activities in the …
Appointment

NICE approves AstraZeneca’s dual immunotherapy for advanced liver cancer

July 30, 2025 Medical Communications, Research and Development AstraZeneca, NHS, National Institute for Health and Care Excellence, Oncology, dual immunotherapy, hepatocellular carcinoma, liver cancer

AstraZeneca has received a positive recommendation from the National Institute for Health and Care Excellence (NICE) for its dual immunotherapy …
News
laboratory-testing-az

Clinisys acquires Orchard Software to expand laboratory informatics leadership

July 30, 2025 Analytical & Laboratory Services, Mergers and Acquisitions, Research and Development Clinisys, Corporate, Francisco Partners, Orchard Software, laboratory informatics, laboratory information management systems

Clinisys has announced the acquisition of Orchard Software from Francisco Partners, strengthening its position in laboratory informatics. The strategic acquisition …
News
alzheimers_brain

Roche receives CE Mark for blood test to help rule out Alzheimer’s

July 30, 2025 Research and Development Alzheimer's disease, CE Mark approval, Eli Lilly, Neurology, Roche

Roche has been granted CE Mark approval for its Elecsys pTau181 test, the first in vitro diagnostic regulation-certified blood-based diagnostic …
News
europe-1395916_640

Sanofi’s Sarclisa gains EU approval for multiple myeloma treatment

July 30, 2025 Medical Communications, Research and Development European Commission, Oncology, Sanofi, Sarclisa, european union, multiple myeloma

Sanofi has received approval from the European Commission for the use of Sarclisa (isatuximab) in combination with bortezomib, lenalidomide, and …
News

ViroCell Biologics and AvenCell Therapeutics partner to accelerate allogeneic CAR-T therapy development

July 29, 2025 Contract Manufacturing, Manufacturing Services, Mergers and Acquisitions, Research and Development AvenCell Therapeutics, CAR-T therapy, Contract Development Manufacturing Organisation, Good Manufacturing Practice, Immunology, Oncology, ViroCell Biologics, autoimmune diseases, blood cancer

ViroCell Biologics has announced a new manufacturing collaboration with AvenCell Therapeutics to produce a high-yield retroviral vector supporting the clinical …
News

Relief Therapeutics to merge with NeuroX to create AI-driven neurohealth company

July 29, 2025 Mergers and Acquisitions, Research and Development AI, Corporate, MindMaze, Neurology, Relief Therapeutics, neurological conditions

Relief Therapeutics has announced that it will combine with NeuroX Group, the successor to digital neurotherapeutics company MindMaze. The transaction …
News

Universal Quantum partners with Open Quantum Institute to tackle endometriosis with new technology

July 29, 2025 Medical Communications, Research and Development Open Quantum Institute, Pain, Reproductive health, UN Sustainable Development Goals, United Nations, Universal Quantum, endometriosis, women's health

Based in Brighton, UK, Universal Quantum has joined the Open Quantum Institute (OQI) to explore how quantum computing could revolutionise …
News
Prescriptions image

Mental health medicine use in England reaches record high, NHSBSA report reveals

July 29, 2025 Manufacturing and Production, Medical Communications, Research and Development ADHD, COVID-19, NHS Business Services Authority, Psychiatry, antidepressants, antipsychotics, anxiolytics, barbiturate, dementia, hypnotics, mental health

According to new data published by the NHS Business Services Authority (NHSBSA), mental health prescriptions in England have reached their …
News

Bristol Myers Squibb appoints Cristian Massacesi as chief medical officer and head of development

July 28, 2025 Research and Development Bristol Myer Squibb, Corporate, Executive Leadership Team, Head of Development, chief medical officer, executive vice president

Bristol Myers Squibb (BMS) has announced the appointment of Cristian Massacesi as executive vice president, chief medical officer, and head …
Appointment

Neuraxpharm appoints Avendran Naidu as head of commercial upon launch of Australian affiliate

July 28, 2025 Manufacturing and Production, Research and Development Neuraxpharm, Neuraxpharm Australia, Neurology, central nervous system, multiple sclerosis

Neuraxpharm Group has announced the launch of Neuraxpharm Australia, furthering its global expansion beyond Europe and into key international markets. …
Appointment
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025